WuXi Biologics (Cayman) Inc. (HKG:2269)
25.90
+0.20 (0.78%)
Jul 9, 2025, 4:08 PM HKT
WuXi Biologics Employees
WuXi Biologics had 12,575 employees as of December 31, 2024. The number of employees decreased by 165 or -1.30% compared to the previous year.
Employees
12,575
Change (1Y)
-165
Growth (1Y)
-1.30%
Revenue / Employee
1.58M HKD
Profits / Employee
284.01K HKD
Market Cap
105.39B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
BeOne Medicines | 11,000 |
Hansoh Pharmaceutical Group Company | 8,989 |
Innovent Biologics | 5,659 |
JD Health International | 3,564 |
Akeso | 3,035 |
Sino Biopharmaceutical | 24,379 |
CSPC Pharmaceutical Group | 21,400 |
Sichuan Kelun-Biotech Biopharmaceutical | 1,837 |
WuXi Biologics News
- 9 days ago - WuXi Biologics Launches Next-Generation Platform WuXiHigh™2.0 for High-Concentration Biologics with Protein Concentration Reaching 230 mg/mL - PRNewsWire
- 21 days ago - Focus: China pharma projects disrupted by Sino-US tensions - Reuters
- 23 days ago - Hong Kong stocks waver on China’s mixed economic data - South China Morning Post
- 4 weeks ago - WuXi Biologics Kicks off Construction of Microbial Manufacturing Site for Commercial Production in Chengdu - PRNewsWire
- 5 weeks ago - Hong Kong stocks jump as US blocks Trump’s tariffs in win for global trade - South China Morning Post
- 7 weeks ago - WuXi Biologics: Eyes On Long-Term Risks And Near-Term Outlook (Rating Downgrade) - Seeking Alpha
- 7 weeks ago - WuXi Biologics Congratulates Partner CANbridge Pharmaceuticals on the Approval of Innovative Velaglucerase-beta for Injection (Gaurunning) for Gaucher Disease by China NMPA - PRNewsWire
- 2 months ago - Driving Impact Through Responsibility: WuXi Biologics Releases 2024 Sustainability Report - PRNewsWire